ArticleScientific reports2026
Phytochemical characterization and antidiabetic potential of Carum carvi L. seeds from Beni Mellal-Khenifra: in vitro, in vivo, in silico and ADME investigations.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-Target Mechanisms of Moroccan Aphrodisiac Plants: An Integrative Computational and Phytochemical Investigation.Food science & nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to analyze the phytochemistry of the aqueous extract of Carum carvi L. seeds (AECCS) from the Beni Mellal-Khenifra region and assess its antihyperglycemic activity and safety. The quantitative phytochemical analysis showed that the studied extract contains 0.27 ± 0.08 mg QE/mg DM and 0.57 ± 0.07 mg GAE/mg DM of flavonoids and polyphenols, respectively. Phytochemical analysis revealed 11 compounds, the most abundant being syringic acid (40.02%), cinnamic acid (26.54%), and 4-hydroxybenzoic acid (10.22%). The aqueous extract showed a significant antihyperglycemic effect in normal Albino mice at 60 min (p < 0.01; 2.15 ± 1.01 g/L) and 90 min (p < 0.05; 1.36 ± 0.52 g/L) after administration of the extract, as well as an inhibitory effect on the enzymatic activity of α-amylase, with an IC50 mg/mL (0.139 ± 0.023 mg/mL) in vitro. Furthermore, it significantly (p < 0.001) reduced postprandial hyperglycemia at 60 min (1.35 ± 0.27 g/L) and at 90 min (1.13 ± 0.17 g/L) in vivo. The extract also showed an inhibitory effect on α-glucosidase activity, with an IC50 of 56.66 ± 1.247 µg/mL in vitro, and it non-significantly reduced postprandial hyperglycemia at 90 min (1.14 ± 0.13 g/L) and 150 min (0.88 ± 0.07 g/L) in vivo. In addition to this pharmacological effect, the aqueous extract produced no hypoglycemic effects on basal blood glucose levels in albino mice and showed no signs of short-term toxicity. Molecular docking revealed that the bioactive compounds from the extract interacted differently with α-amylase and-α-glucosidase. Among them, catechin stands out with an affinity of -7.9 kcal/mol for α-amylase and − 6.9 kcal/mol for α-glucosidase. These compounds comply with Lipinski’s criteria, thus enhancing their potential for drug development. They fall into the mild toxicity category, ranging from moderate to low, with LD₅₀ values between 1034 and 10,000 mg/kg, indicating a good safety margin. Based on these results, which confirm the efficacy of this plant in traditional medicine for the treatment of diabetes, this plant could be used to treat diabetic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.